+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review

Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Henry Schein Inc (Henry Schein) is a provider of health care products and services for dental and medical practitioners. Its product portfolio consists of preventatives, infection-control products, composites, anesthetics, dental implants, generic and branded drugs, vaccines, surgical products and diagnostic tests, among others. It also offers technology solutions such as practice management software, and e-commerce solutions, equipment repair, financial services and other value-added services. The company serves dental practitioners, laboratories and physician practices, government, institutional healthcare clinics, and other alternate care clinics. It operates in Germany, France, Canada, Switzerland, the UK, and the US, among others. Henry Schein is headquartered in Melville, New York, the US.

Henry Schein Inc Key Recent Developments

  • May 22, 2026: Henry Schein Elects William K. “Dan” Daniel as Independent Chairman of the Board
  • May 05, 2026: Henry Schein Reports First Quarter 2026 Financial Results
  • May 04, 2026: Henry Schein to Present at Investor Conferences in May
  • Apr 21, 2026: Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Henry Schein Inc - Key Facts
  • Henry Schein Inc - Key Employees
  • Henry Schein Inc - Key Employee Biographies
  • Henry Schein Inc - Major Products and Services
  • Henry Schein Inc - History
  • Henry Schein Inc - Company Statement
  • Henry Schein Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Henry Schein Inc - Business Description
  • Business Segment: Global Distribution and Value -Added Services
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Global Specialty Products
  • Overview
  • Performance
  • Business Segment: Global Technology
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Other
  • Target Markets
  • Performance
  • Geographical Segment: United States
  • Performance
  • Henry Schein Inc - Corporate Strategy
  • Henry Schein Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Henry Schein Inc - Strengths
  • Henry Schein Inc - Weaknesses
  • Henry Schein Inc - Opportunities
  • Henry Schein Inc - Threats
  • Henry Schein Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Henry Schein Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Henry Schein Inc, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • Henry Schein Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 22, 2026: Henry Schein Elects William K. “Dan” Daniel as Independent Chairman of the Board
  • May 05, 2026: Henry Schein Reports First Quarter 2026 Financial Results
  • May 04, 2026: Henry Schein to Present at Investor Conferences in May
  • Apr 21, 2026: Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026
  • Mar 05, 2026: Henry Schein Unveils New Dallas Discovery Center
  • Mar 04, 2026: Henry Schein to Participate in Upcoming Investor Conferences in March
  • Feb 24, 2026: Henry Schein Reports Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
  • Jan 22, 2026: Henry Schein to Webcast Fourth-Quarter 2025 Conference Call on February 24, 2026
  • Jan 12, 2026: Henry Schein Appoints Frederick M. Lowery as Chief Executive Officer
  • Dec 29, 2025: Henry Schein to Participate in J.P. Morgan Healthcare Investor Conference
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Henry Schein Inc, Key Facts
  • Henry Schein Inc, Key Employees
  • Henry Schein Inc, Key Employee Biographies
  • Henry Schein Inc, Major Products and Services
  • Henry Schein Inc, History
  • Henry Schein Inc, Subsidiaries
  • Henry Schein Inc, Key Competitors
  • Henry Schein Inc, Ratios based on current share price
  • Henry Schein Inc, Annual Ratios
  • Henry Schein Inc, Interim Ratios
  • Henry Schein Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Henry Schein Inc, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • Henry Schein Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Henry Schein Inc, Performance Chart (2021-2025)
  • Henry Schein Inc, Ratio Charts
  • Henry Schein Inc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • Henry Schein Inc, Medical Equipment, Deals by Type, 2020 to YTD 2026

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • VYNE Therapeutics Inc
  • Vyne Medical
  • Proclinic SA
  • Open Dental Software Inc
  • McKesson Corp
  • Good Methods Global Inc
  • GACD Group
  • eClinicalWorks LLC
  • Envista Holdings Corp
  • Curve Dental Inc
  • Cencora Inc
  • Straumann Holding AG
  • Planmeca Oy
  • Epic Systems Corp
  • Carestream Health Inc
  • ZocDoc Inc
  • Weave Communications Inc
  • Solutionreach Inc
  • Patterson Companies Inc
  • Cardinal Health Inc
  • Billericay Dental Supply Co., Ltd. (trading as The Dental Directory)
  • Pluradent AG & Co KG
  • Nuent Group AB
  • LocalMed Inc
  • Benco Dental Supply Company
  • ZimVie Inc
  • Veradigm Inc
  • NextGen Healthcare Inc
  • Medline Industries LP
  • Lifco publ AB
  • ProSites Inc
  • Dentsply Sirona Inc
  • DD Products and Services Ltd